Inna Gertsenshteyn
My name is Inna Gertsenshteyn (EE-nah  GURTZ-en-shtine), and I'm a 5th year PhD candidate in Medical Physics at the University of Chicago. My co-advisors are Dr. Howard Halpern and Dr. Chin-Tu Chen. We are working on multimodal tumor hypoxia imaging with [18]F-Fluoromizonidazole PET, EPR, and DCE-MRI to improve radiation therapy.

Before graduate school I worked as an Image Analyst at Invicro, a global research partner to pharmaceutical, biotech, and contract research organizations, aiming to enhance drug discovery and development.

My general research interests are in anything to do with multimodal imaging and image analysis. Outside of academia, I enjoy hosting house concerts, coffee dates with friends, going on walks, watching movies, and reading books. 


Small animal IMRT using 3D-printed compensators

Gage Redler, Erik Pearson, Xinmin Liu, Inna Gertsenshteyn, Boris Epel, Charles Pelizzari, Bulent Aydogan, Ralph Weichselbaum, Howard Halpern, Rodney D Wiersma

International Journal of Radiation Oncology, Biology, Physics

Development of a PET/EPRI combined imaging system for assessing tumor hypoxia

Heejong Kim, Boris Epel, Subraman Sundramoorthy, Hsiu-Min Tsai, Eugene Barth, Inna Gertsenshteyn, Howard Halpern, Yuexuan Hua, Qingguo Xie, Chin-Tu Chen, Chien-Min Kao

Journal of Instrumentation, 2021

Improving tumor hypoxia location in [18]F-Misonidazole PET with Dynamic Contrast Enhanced MRI using quantitative Electron Paramagnetic Resonance partial oxygen pressure images

Inna Gertsenshteyn, Boris Epel, Eugene Barth, Lara Leoni, Erica Markiewicz, Hsiu-Ming Tsai, Xiaobing Fan, Mihai Giurcanu, Marta Zamora, Subramanian Sundramoorthy, Heejong Kim, Richard Freifelder, Mohammed Bhuiyan, Anna Kucharski, Gregory Karczmar, Chien-Min Kao, Howard Halpern, Chin-Tu Chen

Radiology: Imaging Cancer, vol. 3(2), 2021

Biological validation of electron paramagnetic resonance (EPR) image oxygen thresholds in tissue

Inna Gertsenshteyn, Mihai Giurcanu, Peter Vaupel, Howard Halpern

Journal of Physiology, vol. 599(6), 2021, pp. 1759-1767

News and upcoming presentations 

January 2022: Starting a co-op at Biogen, while still on track to defend my PhD in the summer of 2022.

December 2nd, 2021: Oral presentation at the Radiological Society of North America Annual Meeting on "Validation of multimodal hypoxia imaging using pO2 EPR, FMISO PET, and DCE MRI with H&E, CD31, and HIF1 α staining on SCC7 squamous cell carcinomas." 

July 29th, 2021: Oral presentation at the International Society on Oxygen Transport to Tissue on "Validation and correction of [18]F-Misonidazole PET with pO2 EPR and

June 12th, 2021: Selected as the 1st place CMIIT Young Investigator Award recipient at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, for abstract titled “Optimal [18]F-Misonidazole PET threshold to locate SCC7 tumor hypoxia using EPR pO2 as ground truth.”

April 2021: Recipient of an NIH F31 Ruth L. Kirchstein National Research Service Award for my dissertation project: "Correcting [18]F-Misonidazole PET with MRI and EPR to improve hypoxia-guided radiation therapy."